JP2023528805A5 - - Google Patents

Info

Publication number
JP2023528805A5
JP2023528805A5 JP2022573214A JP2022573214A JP2023528805A5 JP 2023528805 A5 JP2023528805 A5 JP 2023528805A5 JP 2022573214 A JP2022573214 A JP 2022573214A JP 2022573214 A JP2022573214 A JP 2022573214A JP 2023528805 A5 JP2023528805 A5 JP 2023528805A5
Authority
JP
Japan
Prior art keywords
rna
puromycin
polypeptide
tagged
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022573214A
Other languages
English (en)
Japanese (ja)
Other versions
JP7854946B2 (ja
JP2023528805A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/034131 external-priority patent/WO2021242793A2/en
Publication of JP2023528805A publication Critical patent/JP2023528805A/ja
Publication of JP2023528805A5 publication Critical patent/JP2023528805A5/ja
Priority to JP2026070113A priority Critical patent/JP2026117232A/ja
Application granted granted Critical
Publication of JP7854946B2 publication Critical patent/JP7854946B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022573214A 2020-05-26 2021-05-26 核酸人工ミニプロテオームライブラリー Active JP7854946B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026070113A JP2026117232A (ja) 2020-05-26 2026-04-21 核酸人工ミニプロテオームライブラリー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063030056P 2020-05-26 2020-05-26
US63/030,056 2020-05-26
PCT/US2021/034131 WO2021242793A2 (en) 2020-05-26 2021-05-26 Nucleic acid artificial mini-proteome libraries

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026070113A Division JP2026117232A (ja) 2020-05-26 2026-04-21 核酸人工ミニプロテオームライブラリー

Publications (3)

Publication Number Publication Date
JP2023528805A JP2023528805A (ja) 2023-07-06
JP2023528805A5 true JP2023528805A5 (cg-RX-API-DMAC10.html) 2024-06-04
JP7854946B2 JP7854946B2 (ja) 2026-05-07

Family

ID=76859704

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022573214A Active JP7854946B2 (ja) 2020-05-26 2021-05-26 核酸人工ミニプロテオームライブラリー
JP2026070113A Pending JP2026117232A (ja) 2020-05-26 2026-04-21 核酸人工ミニプロテオームライブラリー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026070113A Pending JP2026117232A (ja) 2020-05-26 2026-04-21 核酸人工ミニプロテオームライブラリー

Country Status (8)

Country Link
US (1) US20230203477A1 (cg-RX-API-DMAC10.html)
EP (1) EP4158014A2 (cg-RX-API-DMAC10.html)
JP (2) JP7854946B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230029673A (cg-RX-API-DMAC10.html)
CN (1) CN116249774A (cg-RX-API-DMAC10.html)
AU (1) AU2021280261A1 (cg-RX-API-DMAC10.html)
CA (1) CA3185387A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021242793A2 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023034901A1 (en) 2021-09-01 2023-03-09 The Broad Institute, Inc. Tumor avatar vaccine compositions and uses thereof
US12112833B2 (en) 2020-02-04 2024-10-08 10X Genomics, Inc. Systems and methods for index hopping filtering
US12168801B1 (en) * 2020-07-02 2024-12-17 10X Genomics, Inc. Hybrid/capture probe designs for full-length cDNA
US12580044B1 (en) 2020-09-02 2026-03-17 10X Genomics, Inc. Systems and methods for identifying cells that are antigen-specific for an immunogenic feature
US20250144198A1 (en) * 2021-08-16 2025-05-08 Duke University Next generation vaccines comprising antigenic libraries and methods of making and using same
WO2023076733A1 (en) * 2021-11-01 2023-05-04 Dana-Farber Cancer Institute, Inc. Biologically selected nucleic acid artificial mini-proteome libraries
EP4594488A1 (en) * 2022-09-29 2025-08-06 Twist Bioscience Corporation Libraries for rna enrichment

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870790A (en) 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
US4226859A (en) 1979-06-07 1980-10-07 Velsicol Chemical Corporation Pyridyl esters of N-alkylidene-substituted phosphor- and phosphonamidic acids
ZA825384B (en) 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
US4369172A (en) 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US5364773A (en) 1991-03-07 1994-11-15 Virogenetics Corporation Genetically engineered vaccine strain
DE3583799D1 (de) 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
CA1341245C (en) 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
JP2773959B2 (ja) 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
EP0575491B1 (en) 1991-03-07 2003-08-13 Virogenetics Corporation Genetically engineered vaccine strain
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
ES2243937T3 (es) 1994-04-29 2005-12-01 Baxter Healthcare S.A. Poxvirus recombinados en regiones esenciales con la ayuda de polinucleotidos extraños.
US5705190A (en) 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US7255862B1 (en) 1996-11-14 2007-08-14 Connaught Technology Corporation ALVAC/FIV constructs
WO1999014354A1 (en) 1997-09-19 1999-03-25 The Trustees Of The University Of The Pennsylvania Methods and vector constructs useful for production of recombinant aav
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
US6413776B1 (en) 1998-06-12 2002-07-02 Galapagos Geonomics N.V. High throughput screening of gene function using adenoviral libraries for functional genomics applications
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
WO2000006717A2 (en) 1998-07-27 2000-02-10 Genentech, Inc. Improved transformation efficiency in phage display through modification of a coat protein
EP1101490B1 (en) 1998-07-28 2005-04-13 Tanabe Seiyaku Co., Ltd. Preparation capable of releasing drug at target site in intestine
CA2334946A1 (en) * 1998-08-17 2000-02-24 Phylos, Inc. Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation
US6955808B2 (en) 1999-09-24 2005-10-18 Uab Research Foundation Capsid-modified recombinant adenovirus and methods of use
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
ES2376454T3 (es) 2000-12-22 2012-03-14 Grad, Carole, Legal Representative Of Howard, Kaplan Librer�?as de expresión en fago de fragmentos vh humanos.
US7501127B2 (en) 2002-05-16 2009-03-10 Bavarian Nordic A/S Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara
WO2005035751A1 (ja) * 2003-10-15 2005-04-21 Keio University 高機能性タンパク質の迅速、高効率な選択法、それによって得られる高機能性タンパク質、およびその製造方法と利用方法
EP2397490B1 (en) 2004-07-16 2013-09-04 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vaccine constructs and combinations of vaccines designed to improve the breadth of the immune response to diverse strains and clades of HIV
EP2573185A3 (en) 2005-02-16 2013-06-05 Lentigen Corporation Lentiviral vectors and their use
JP2011512326A (ja) 2007-12-31 2011-04-21 ナノコア セラピューティクス,インコーポレイテッド 心不全の治療用のrna干渉
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit
LT2714071T (lt) 2011-05-24 2019-10-10 Biontech Rna Pharmaceuticals Gmbh Individualizuotos vakcinos nuo vėžio
WO2012159643A1 (en) 2011-05-24 2012-11-29 Biontech Ag Individualized vaccines for cancer
WO2018213803A1 (en) * 2017-05-19 2018-11-22 Neon Therapeutics, Inc. Immunogenic neoantigen identification
WO2020018461A1 (en) * 2018-07-16 2020-01-23 The University Of Virginia Patent Foundation Compositions and methods of diagnosis and treatment for neurological diseases

Similar Documents

Publication Publication Date Title
EP0590689B1 (fr) Procédé d'obtention d'ADN, ARN, peptides, polypeptides ou protéines, par une technique de recombinaison d'ADN
Tusup et al. Design of in vitro transcribed mRNA vectors for research and therapy
ATE426022T1 (de) Prozess, konstrukt und konjugat zur herstellung mehrerer nukleinsaurekopien
JP2000157291A (ja) 大きな構造遺伝子の製造および発現
JP2004535163A (ja) Rnaポリメラーゼから誘導されたポリペプチド及びそれらの使用
EP3651781A1 (en) Methods and systems for conditionally regulating gene expression
JP2020510426A5 (cg-RX-API-DMAC10.html)
HU196237B (en) Process for producing human growth prehormone
WO2025102442A9 (zh) 一种基于人源tRNA的自环化RNA
KR20220004060A (ko) T-세포 수용체 유전자 어셈블리를 위한 조성물 및 방법
CN115485379A (zh) 用于体外mRNA转录的合成DNA模板
JP2023500116A5 (cg-RX-API-DMAC10.html)
LU82757A1 (fr) Genes de la proinsuline humaine et de pre-proinsuline humaine,leur procede de preparation et leurs applications
CN111410695B (zh) 基于自噬机制介导Tau蛋白降解的嵌合分子及其应用
CN111448320B (zh) 细胞膜穿透肽
CA2195090A1 (en) Lkp pilin structural genes and operon of nontypable haemophilus influenzae
WO2025097031A1 (en) Compositions and methods for cell therapy
CN117887667A (zh) 一种用于快速生成car-nk细胞的工程化外泌体的制备方法和应用
CN117062912A (zh) 用于基于crispr的转录抑制的融合蛋白
JP3680392B2 (ja) マイクロ遺伝子のランダム重合体作成方法
CN121344095B (zh) 一种细胞内mRNA传感器开关的DNA文库筛选方法及应用
WO2025190256A1 (en) Type ii cas protein and uses thereof
LU103548B1 (en) Eukaryotic expression plasmid for recombinant porcine macrophage-colony stimulating factor (pm-csf), method of constructing same and use thereof
JP5109040B2 (ja) ヒト一本鎖抗体遺伝子断片の効率的な新規調製法
HK40118372A (zh) 一种通用的制备环状rna的方法及其用途